ImprovINg the TIMEly Diagnosis and Treatment of Cancer and Cardio-metabolic Diseases in People With Mental Disorders: Reducing Health Disparities Through Integrated Care
IN-TIME
2 other identifiers
observational
120
0 countries
N/A
Brief Summary
One in five people in Italy has a mental disorder, with depression being the most common and schizophrenia the most severe. People with mental illness have a higher risk of cardio-metabolic and oncologic comorbidities. They also face disparities in accessing appropriate care, with a 20-year life expectancy reduction. IN-TIME will employ an innovative and highly interdisciplinary approach to characterize barriers to healthcare in people with mental illness for informing interventions and enhancing screening, diagnostic pathways and health outcomes. The project will provide: 1) population-based evidence and characterization of disparities in diagnosis and care for cancer and cardio-metabolic disorders; 2) a fine-grained identification of modifiable barriers, such as those relating to stigma and communication; 3) change promoting interventions, including a policy brief to orient clinical guidelines and best practice to reduce stigma, improve doctor-patient communication and optimize care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2026
CompletedFirst Posted
Study publicly available on registry
September 28, 2026
CompletedStudy Start
First participant enrolled
November 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2029
Study Completion
Last participant's last visit for all outcomes
November 1, 2029
September 28, 2026
September 1, 2026
2.6 years
September 21, 2026
September 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Timely access to cancer and cardiometabolic screening and early diagnosis and related healthcare barriers
For the observational cross-sectional part of the study, the investigators will assess barriers to timely access to cancer and cardiometabolic screening, diagnosis and care in adult patients with schizophrenia spectrum disorder, depressive disorder or bipolar disorder. Participants will undergo standardized assessments and an ad-hoc semi-structured interview exploring personal experiences of healthcare access, screening, diagnostic pathways, communication with healthcare professionals, and perceived barriers and facilitators to care. Interviews will be audio-recorded and analysed using qualitative methods and Natural Language Processing (NLP). A total of 120 participants will be enrolled at two sites: IRCCS Ospedale San Raffaele (n=60) and ASST Santi Paolo e Carlo (n=60).
Baseline
Study Arms (1)
People with severe mental disorders
Interventions
Not applicable - observational study
Eligibility Criteria
Potential participants will be identified through outpatient clinics at IRCCS Ospedale San Raffaele and ASST Santi Paolo e Carlo. Eligible participants will be approached and invited to participate in the study and will undergo screening based on predefined eligibility criteria. The target population includes adults aged 40-70 years with schizophrenia spectrum disorder, depressive disorder, or bipolar disorder. A total of 120 participants will be recruited, 60 at each study site, with both sexes included.
You may qualify if:
- Age 40-70 years;
- ICD-10 diagnosis of schizophrenia spectrum disorder (F20-F29), depressive disorder (F32-F33), or bipolar disorder (F31);
- Ability to provide written informed consent.
- Both sexes are eligible.
- Participants recruited at IRCCS Ospedale San Raffaele or ASST Santi Paolo e Carlo.
You may not qualify if:
- Age \<40 years or \>70 years.
- Inability to provide informed consent.
- Absence of an ICD-10 diagnosis of schizophrenia spectrum disorder (F20-F29), depressive disorder (F32-F33), or bipolar disorder (F31).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IRCCS San Raffaelelead
- Istituto Universitario di Studi Superiori - IUSScollaborator
- DG Welfare Regione Lombardiacollaborator
- University College, Londoncollaborator
- ASST Santi Paolo e Carlocollaborator
- HPA (Health Protection Agency) of the Metropolitan City of Milancollaborator
- Accademia Lombarda di Sanità Pubblicacollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor and Medical Doctor
Study Record Dates
First Submitted
September 21, 2026
First Posted
September 28, 2026
Study Start (Estimated)
November 1, 2026
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
November 1, 2029
Last Updated
September 28, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share